Linked-in Link Twitter Link

Innova Partnerships’ Latest Portfolio Company, Vitamica Ltd, Spun Out of the University of Bristol

Apr 20, 2018

Innova Partnerships is pleased to announce that its latest portfolio company, Vitamica Ltd, is a spin out from the University of Bristol.

The Company has been formed to commercialise the ground-breaking work of Dr Massimo Antognozzi, from the Department of Physics, who has used optical analysis of live bacteria to measure changes in their response to antibiotics. The technique has demonstrated a fast and accurate technique that can be used to assess antimicrobial resistance of bacteria. This will open up applications for personalised medicine and should help stem the over use of antibiotics.

The University of Bristol and Innova Partnerships worked together to evaluate the opportunity which led to the formation of the spin out. Over a period of 9 months Innova worked with the team at the University to bring together the elements for a successful start up that included pulling together an investor ready business plan, bringing together an experienced founding management team and securing seed financing, alongside support from an Innovate UK grant.

Commenting, Innova Partnerships’ Director of Business Development, Dr Paul Meakin, said, “It has been a pleasure to work with the team at the University of Bristol to get Vitamica off the ground. This is a great example of each party playing to their strengths. We see huge potential in Vitamica and look forward to helping bring products to market that can really benefit patients.”

Dr Paul Meakin has taken up the role of CEO and joins Dr Massimo Antognozzi (CSO) and Ms Jaci Barnett (Director) on the Board of the company.